Citadel Advisors
GDTC icon

Citadel Advisors’s CytoMed Therapeutics GDTC Stock Holding History

Citadel Advisors’s Portfolio GDTC Stock Details GDTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$58.9K Buy
27,669
+10,419
+60% +$22.2K ﹤0.01% 5428
2025
Q1 		$38.8K Buy
+17,250
New +$38.8K ﹤0.01% 5437